Profil
John Paul Gabriel is currently Chief Technical Operations Officer at Silence Therapeutics Plc since 2022.
Formerly, Mr. Gabriel was Senior Vice President-Technical Operations at Ocugen, Inc. from 2021 to 2022 and Vice President-Biologics & mRNA Manufacturing at Ultragenyx Pharmaceutical, Inc. Education includes an undergraduate degree from the University of Guelph.
Aktive Positionen von J.P. Gabriel
| Unternehmen | Position | Beginn |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2022 |
Ehemalige bekannte Positionen von J.P. Gabriel
| Unternehmen | Position | Ende |
|---|---|---|
| OCUGEN, INC. | Corporate Officer/Principal | 01.09.2022 |
| ULTRAGENYX PHARMACEUTICAL INC. | Corporate Officer/Principal | - |
Ausbildung von J.P. Gabriel
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Ultragenyx Pharmaceutical, Inc.
Ultragenyx Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel products for the treatment of serious rare and ultra-rare genetic diseases | Health Technology |
Silence Therapeutics Plc
Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
University of Guelph
University of Guelph Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ocugen, Inc.
Ocugen, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes gene therapy products | Health Technology |
















